Q
QuantAbundance

Notícias

Apenas manchetes de alto sinal - eventos macro, resultados, M&A, regulatório. Listicles e clickbait de analistas filtrados por padrão. Atualizado a cada hora.

30,677 signal articles · 42 in last 24h · 156,094 total before filter · latest 1h ago
42last 24h
854last 7d
150● bullish (7d)
86● bearish (7d)
214publishers
AllMacro190Earnings112M&A124Regulatory20Product19Analyst21
✕ clear all filtersSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
KBR Q2 Earnings Call Highlights
MarketBeat58d agoneutral
KBR Q2 Earnings Call Highlights

KBR (NYSE:KBR) reported second-quarter 2026 revenue of approximately $2 billion, up 2% from the prior-year period, while adjusted EBITDA rose $16 million to $258 million and adjusted EPS increased $0.08 to $0.99. The company said first-half results were tracking slightly ahead of its planned cadence

Kinross Gold Q2 Earnings Call Highlights
MarketBeat58d agoneutral
Kinross Gold Q2 Earnings Call Highlights

Kinross Gold (NYSE:KGC) reported second-quarter production of 492,000 gold equivalent ounces and attributable free cash flow of $727 million, as the company said it remains on track to meet its 2026 production, cost and capital-spending guidance. Chief Executive Officer Paul Rollinson said the comp

Cameco (CCJ) Q2 Earnings Miss Estimates
Zacks58d agobearish
Cameco (CCJ) Q2 Earnings Miss Estimates

Cameco (CCJ) delivered earnings and revenue surprises of -50.00% and +10.04%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Moderna Earnings Are Better Than Expected So Why Is the Stock Falling?
Barrons.com58d agobullish
Moderna Earnings Are Better Than Expected So Why Is the Stock Falling?

Moderna posted a narrower per-share loss and higher revenue in its latest quarter, but shares were tumbling anyway. Moderna posted a loss of $1.97 a share, narrower than the loss of $2.01 Wall Street had anticipated, and slimmer than the per-share loss of $2.13 reported last year. The drugmaker reiterated its full-year guidance of 10% revenue growth, evenly split between U.S. and international sales.

Moderna (NASDAQ:MRNA) Beats Expectations in Q2 CY2026
StockStory58d agobullish
Moderna (NASDAQ:MRNA) Beats Expectations in Q2 CY2026

Biotechnology company Moderna (NASDAQ:MRNA) reported Q2 CY2026 results exceeding the market’s revenue expectations, with sales up 2.1% year on year to $145 million. Its GAAP loss of $1.97 per share was 4.2% above analysts’ consensus estimates.

IDACORP Q2 Earnings Call Highlights
MarketBeat58d agoneutral
IDACORP Q2 Earnings Call Highlights

IDACORP (NYSE:IDA) raised the lower end of its 2026 earnings guidance after reporting higher second-quarter profit, supported by January rate changes, customer growth and an early ramp in revenue from large industrial customers. The utility holding company reported second-quarter diluted earnings p

Intercontinental Exchange Q2 Earnings Call Highlights
MarketBeat58d agoneutral
Intercontinental Exchange Q2 Earnings Call Highlights

Intercontinental Exchange (NYSE:ICE) reported record second-quarter results and announced an agreement to acquire electronic bond-trading platform MarketAxess for $167 per share, a transaction valued at $5.7 billion in enterprise value. Chair and CEO Jeff Sprecher said the proposed acquisition woul

Hexcel Q2 Earnings Call Highlights
MarketBeat58d agoneutral
Hexcel Q2 Earnings Call Highlights

Hexcel (NYSE:HXL) reported higher second-quarter sales, margins and cash flow as commercial aircraft production rates increased, led by demand on wide-body programs including the Airbus A350 and Boeing 787. Second-quarter sales totaled $529 million, up 8% from the prior-year period, while adjusted

Huntington Ingalls Industries Q2 Earnings Call Highlights
MarketBeat58d agoneutral
Huntington Ingalls Industries Q2 Earnings Call Highlights

Huntington Ingalls Industries (NYSE:HII) reported second-quarter 2026 sales of $3.4 billion and diluted earnings per share of $5.27, as higher volumes at its shipbuilding operations helped drive revenue growth and prompted the company to raise its full-year shipbuilding outlook. Chief Executive Off

Do Upbeat Earnings Revisions Quietly Recast Analog Devices’ (ADI) Automation and AI Earnings Power?
Simply Wall St.58d agobullish
Do Upbeat Earnings Revisions Quietly Recast Analog Devices’ (ADI) Automation and AI Earnings Power?

Recently, Analog Devices drew increased investor interest as analysts raised their earnings estimates and Zacks assigned the company a Rank #2, often interpreted as a signal of potentially stronger near-term performance. This revision trend highlights how shifting profit expectations can reshape perceptions of Analog Devices’ earnings power across key end markets like industrial and automotive. Now we’ll examine how these upward earnings revisions may influence Analog Devices’ existing...